Literature DB >> 22836906

Lung-cancer related chest events detected by periodical follow-up CT after stereotactic body radiotherapy for stage I primary lung cancer: retrospective analysis of incidence of lung-cancer related chest events and outcomes of salvage treatment.

Yasushi Hamamoto1, Masaaki Kataoka, Motohiro Yamashita, Naoyuki Nogami, Yoshifumi Sugawara, Toshiyuki Kozuki, Shigeki Sawada, Hiroshi Suehisa, Syuichi Shinohara, Naomi Nakajima, Tetsu Shinkai.   

Abstract

PURPOSE: Follow-up by chest CT is often performed routinely after stereotactic body radiotherapy (SBRT) for primary lung cancer. We investigated how often periodical chest CT detected lung-cancer related chest events (failure in the chest, new primary lung cancer), and how often chest CT follow-ups led to curative intent salvage treatment.
MATERIALS AND METHODS: Between 2006 and 2009, 90 stage I primary lung cancers in 86 patients received SBRT. In principle, chest CT was scheduled every 2-3 months in the first two years, and every 3-4 months thereafter.
RESULTS: Median time to follow-up by chest CT was 26 months (1-61 months). Twenty-seven lung-cancer related chest events were detected by periodical chest CT after SBRT. The three-year lung-cancer related chest event free rate was 62 %. It was possible to apply curative-intent salvage treatment to 56 % of the lung-cancer related chest events. The two-year overall survival rate was 66 % among the 13 patients who received curative-intent salvage treatment (radiotherapy, 11; surgery, 2).
CONCLUSION: Post-SBRT lung-cancer related chest events (as detected by periodical chest CT) were not uncommon (approximately 40 % at 3 years from SBRT), and it was possible to treat more than half of these lesions with curative-intent salvage treatment.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22836906     DOI: 10.1007/s11604-012-0107-2

Source DB:  PubMed          Journal:  Jpn J Radiol        ISSN: 1867-1071            Impact factor:   2.374


  6 in total

1.  Stereotactic body radiation therapy for inoperable early stage lung cancer.

Authors:  Robert Timmerman; Rebecca Paulus; James Galvin; Jeffrey Michalski; William Straube; Jeffrey Bradley; Achilles Fakiris; Andrea Bezjak; Gregory Videtic; David Johnstone; Jack Fowler; Elizabeth Gore; Hak Choy
Journal:  JAMA       Date:  2010-03-17       Impact factor: 56.272

2.  Stereotactic body radiation therapy for early-stage non-small-cell lung carcinoma: four-year results of a prospective phase II study.

Authors:  Achilles J Fakiris; Ronald C McGarry; Constantin T Yiannoutsos; Lech Papiez; Mark Williams; Mark A Henderson; Robert Timmerman
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-02-27       Impact factor: 7.038

3.  Salvage lung resection for non-small cell lung cancer after stereotactic body radiotherapy in initially operable patients.

Authors:  Fengshi Chen; Yukinori Matsuo; Akihiko Yoshizawa; Toshihiko Sato; Hiroaki Sakai; Toru Bando; Kenichi Okubo; Keiko Shibuya; Hiroshi Date
Journal:  J Thorac Oncol       Date:  2010-12       Impact factor: 15.609

4.  Surgical treatment of local recurrence after stereotactic body radiotherapy for primary and metastatic lung cancers.

Authors:  Shinya Neri; Yutaka Takahashi; Takuya Terashi; Hiroshi Hamakawa; Keisuke Tomii; Nobuyuki Katakami; Masaki Kokubo
Journal:  J Thorac Oncol       Date:  2010-12       Impact factor: 15.609

5.  Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy.

Authors:  Pia Baumann; Jan Nyman; Morten Hoyer; Berit Wennberg; Giovanna Gagliardi; Ingmar Lax; Ninni Drugge; Lars Ekberg; Signe Friesland; Karl-Axel Johansson; Jo-Asmund Lund; Elisabeth Morhed; Kristina Nilsson; Nina Levin; Merete Paludan; Christer Sederholm; Anders Traberg; Lena Wittgren; Rolf Lewensohn
Journal:  J Clin Oncol       Date:  2009-05-04       Impact factor: 44.544

6.  Stereotactic body radiation therapy for early stage non-small cell lung cancer: results of a prospective trial.

Authors:  Umberto Ricardi; Andrea Riccardo Filippi; Alessia Guarneri; Francesca Romana Giglioli; Patrizia Ciammella; Pierfrancesco Franco; Cristina Mantovani; Piero Borasio; Giorgio Vittorio Scagliotti; Riccardo Ragona
Journal:  Lung Cancer       Date:  2009-06-24       Impact factor: 5.705

  6 in total
  4 in total

Review 1.  Management of local recurrences and regional failure in early stage non-small cell lung cancer after stereotactic body radiation therapy.

Authors:  Sameera S Kumar; Ronald C McGarry
Journal:  Transl Lung Cancer Res       Date:  2019-09

2.  Salvage surgery for local failures after stereotactic ablative radiotherapy for early stage non-small cell lung cancer.

Authors:  Naomi E Verstegen; Alexander P W M Maat; Frank J Lagerwaard; Marinus A Paul; Michel I Versteegh; Joris J Joosten; Willem Lastdrager; Egbert F Smit; Ben J Slotman; Joost J M E Nuyttens; Suresh Senan
Journal:  Radiat Oncol       Date:  2016-10-03       Impact factor: 3.481

3.  Short report: interim safety results for a phase II trial measuring the integration of stereotactic ablative radiotherapy (SABR) plus surgery for early stage non-small cell lung cancer (MISSILE-NSCLC).

Authors:  David A Palma; Timothy K Nguyen; Keith Kwan; Stewart Gaede; Mark Landis; Richard Malthaner; Dalilah Fortin; Alexander V Louie; Eric Frechette; George B Rodrigues; Brian Yaremko; Edward Yu; A Rashid Dar; Ting-Yim Lee; Al Gratton; Andrew Warner; Aaron Ward; Richard Inculet
Journal:  Radiat Oncol       Date:  2017-01-27       Impact factor: 3.481

4.  A Systematic Literature Review on Salvage Radiotherapy for Local or Regional Recurrence After Previous Stereotactic Body Radiotherapy for Lung Cancer.

Authors:  Yukinori Matsuo
Journal:  Technol Cancer Res Treat       Date:  2018-01-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.